CASIF — CASI Pharmaceuticals, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1962738 ·
Last close
$0.13
Market Cap
$2.67M
52W High
$2.13
52W Low
$0.05
ADV30
1,643
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | 79,329,000 |
| Dec 2025 | 7,222,000 | 3,693,000 | -11,654,000 | -13,043,000 | 25,650,000 | 5,632,000 | 62,932,000 |
| Sep 2025 | 3,075,000 | 706,000 | -10,244,000 | -10,883,000 | 24,462,000 | 4,685,000 | 53,054,000 |
| Jun 2025 | 4,175,000 | 2,058,000 | -10,710,000 | -13,375,000 | 31,202,000 | 6,740,000 | 51,512,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-748,133,000
Inventory
$1,598,000
Receivables
$4,092,000
ST Investments
$0
EBIT TTM
$-45,031,000
Pretax Income TTM
$-45,871,000
Interest Exp TTM
$840,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$20,114,000
EBITDA
$-37,616,000
Free Cash Flow
$-650,750
Enterprise Value
$39,609,616
Total Cash
$3,765,000
Total Debt
$40,497,000
Shares Out
20,555,873
Trailing EPS
$-2.00
Book Value
$-2.83
ROE
—
ROA
-91.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 20,712,000 | -42,846,000 | -48,058,000 | 25,650,000 | 62,932,000 | -37,282,000 | -20,754,000 |
| Dec 2024 | 28,537,000 | -39,212,000 | -39,258,000 | 53,674,000 | 51,823,000 | 1,851,000 | -29,224,000 |
| Dec 2023 | 33,879,000 | -25,280,000 | -26,938,000 | 75,268,000 | 51,103,000 | 24,165,000 | -19,967,000 |
| Dec 2022 | 43,107,000 | -26,491,000 | -41,014,000 | 96,234,000 | 29,302,000 | 44,574,000 | -21,088,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VBIO | Valion Bio, Inc. | $2.69M | $3.03 | — |
| GNPX | Genprex, Inc. | $2.70M | $3.29 | — |
| VCNX | VACCINEX, INC. | $2.60M | $0.97 | — |
| TCRT | Alaunos Therapeutics, Inc. | $2.77M | $1.09 | — |
| ISCO | International Stem Cell CORP | $2.80M | $0.35 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.